000			02038 a2200601 4500
005			20250516114534.0
264		0	_c20130104
008			201301s 0 0 eng d
022			_a1439-099X
024	7		_a10.1007/s00066-012-0169-1 _2doi
040			_aNLM _beng _cNLM
100	1		_aMüller, A-C
245	0	0	_aToxicity and outcome of pelvic IMRT for node-positive prostate cancer. _h[electronic resource]
260			_bStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] _cNov 2012
300			_a982-9 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAndrogen Antagonists _xtherapeutic use
650	0	4	_aBiomarkers, Tumor _xblood
650	0	4	_aCombined Modality Therapy
650	0	4	_aHumans
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aLymph Node Excision
650	0	4	_aLymphatic Metastasis _xpathology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultimodal Imaging
650	0	4	_aNeoplasm Grading
650	0	4	_aNeoplasm Staging
650	0	4	_aPositron-Emission Tomography
650	0	4	_aProstate-Specific Antigen _xblood
650	0	4	_aProstatectomy
650	0	4	_aProstatic Neoplasms _xmortality
650	0	4	_aRadiation Injuries _xetiology
650	0	4	_aRadiotherapy Dosage
650	0	4	_aRadiotherapy, Adjuvant
650	0	4	_aRadiotherapy, Intensity-Modulated _xadverse effects
650	0	4	_aRectum _xpathology
650	0	4	_aSurvival Analysis
650	0	4	_aTomography, X-Ray Computed
650	0	4	_aUrinary Bladder _xpathology
700	1		_aLütjens, J
700	1		_aAlber, M
700	1		_aEckert, F
700	1		_aBamberg, M
700	1		_aSchilling, D
700	1		_aBelka, C
700	1		_aGanswindt, U
773	0		_tStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] _gvol. 188 _gno. 11 _gp. 982-9
856	4	0	_uhttps://doi.org/10.1007/s00066-012-0169-1 _zAvailable from publisher's website
999			_c22173161 _d22173161